Physician profile
Justin T Davis
NPI 1487817946
$23,612.06
in general payments reported to CMS, 2019-2025
11 companies · $2,804 in 2025
The $2,804 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,265 · 2020: $134 · 2021: $222 · 2022: $2,083 · 2023: $137 · 2024: $15K · 2025: $2,804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $5,327 · Food and Beverage: $905 · Entertainment: $224 · Gift: $51.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,400.00 |
| Travel and Lodging | $5,326.60 |
| Food and Beverage | $905.35 |
| Entertainment | $223.53 |
| Gift | $51.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $18,166.78 | 2021-2025 | Magnetos |
| Globus Medical, INC. | $3,756.93 | 2019-2023 | Excelsiusgps Robotic Navigation System |
| Si-Bone, INC. | $1,028.59 | 2019-2023 | |
| Depuy Synthes Sales INC. | $238.01 | 2019-2020 | |
| Medtronic USA, INC. | $119.15 | 2019 | |
| Smith+Nephew, INC. | $116.32 | 2019 | |
| Alphatec Spine, INC | $62.56 | 2024 | Invictus Mis |
| Orthofix Medical, INC. | $58.58 | 2019 | |
| Chiesi USA, INC. | $37.19 | 2022 | |
| Zimmer Biomet Holdings, INC. | $27.95 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.